Displacement of warfarin from human serum proteins by halothane anaesthesia.
The in vitro effects of the halothane metabolite, trifluoroacetic acid, on the binding of warfarin to human serum proteins have been investigated. An increase in the percentage of free warfarin following incubation with different concentrations of trifluoroacetic acid (1 and 4 mmol/l) was observed. In addition, protein binding of warfarin was studied in serum from patients undergoing halothane anaesthesia (1-2.5%; 2.5 h). After 24 h from the end of the halothane anaesthesia, an increase in the percentage of free warfarin was also detected (0.92 +/- 0.06% at 24 h vs 0.60 +/- 0.02% before halothane administration; P less than 0.005). We conclude that halothane anaesthesia may temporarily potentiate the pharmacological effect of warfarin in the postoperative period following anaesthetic procedures.
Calvo
R
R
Department of Pharmacology, University of Basque Country, Leioa, Spain.
Aguilera
L
L
Suárez
E
E
Rodriguez-Sasiaín
J M
JM
D000328:Adult; D001667:Binding, Competitive; D001798:Blood Proteins / Q000378:metabolism*; D005260:Female; D005463:Fluoroacetates / Q000494:pharmacology*; D006221:Halothane / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D011485:Protein Binding / Q000187:drug effects; D014269:Trifluoroacetic Acid / Q000494:pharmacology*; D014859:Warfarin / Q000097:blood*
D001798:Blood Proteins; D005463:Fluoroacetates; D014859:Warfarin; D014269:Trifluoroacetic Acid; D006221:Halothane